Cannabis Science Inc. Cannabis Science Inc.
Cannabis Science Inc. Cannabis Science Inc.
  • Home
  • About Us
    • Corporate Overview
    • Mission Statement
    • Cannabis Science Team
    • Careers & Corporate Culture
  • iCannabinoid
    • Join Now!
  • R&D
    • The Science of Cannabinoids
    • CBIS Cannabinoid Research
    • Critical Ailments
  • COLLABORATIONS & PROJECTS
    • CBIS Medical Consortium
    • Global Economic Development
    • Pan African A & C University
    •     African Economic Initiative
    • American States University
    •     North American Economic Initiative
    • Dana-Farber
    • CFA
    • Stellenbosch University
    • CBIS Bottle It
  • Products & Pharmacies
    • Products
    • Order Online
    • Pharmacies
  • Investors
    • CBIS Current Share Structure
    • SEC Filings
  • Media
    • CBIS News Releases
    • CBIS In The News
    • CBIS Events
  • Contact

latest Articles

  • Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
  • Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
  • Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
  • Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
  • Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations

  1. Home

Total: 448 results found.

Page 21 of 23

Crown Baus Capital (OTC: CBCA) Acquires Military Grade CryptoGraphic Secure Online Communications System; Cannabis Science (OTC: CBIS) Measures Asset Backed Blockchain CryptoCurrency Usage with CryptoGraphic Systems Integration

Created on 2018-02-15 19:59:59

Cannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers Journals

Created on 2018-02-15 19:54:31

Critical Ailments

Created on 2018-02-09 08:17:45

Cali Rx Pharmacy Opening.

Created on 2018-02-06 00:31:07

Global Health Catalyst Summit 2017.

Created on 2018-02-06 00:30:13

CBIS Africa Trip 2016.

Created on 2018-02-06 00:29:53

Dana-Farber / Harvard Cancer Center Invitation.

Created on 2018-02-06 00:29:53

Events

Created on 2018-02-04 19:01:37

Pharmacies

Created on 2018-02-04 07:00:18

Product Development.

Created on 2018-02-04 06:58:09

Cannabis Science Prepares the Grand Openings for Its First Two Pharmacies in California and the Cannabis Science 2018 Black-Tie Gala Event Date to be Announced Right After the Grand Openings

Created on 2018-02-04 04:07:47

Cannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing Cannabinoid-Based Medicines

Created on 2018-02-04 04:06:04

Cannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers

Created on 2018-02-04 04:04:43

CBIS Cannabinoid Research.

Created on 2018-02-03 20:51:00

Stellenbosch University

Created on 2018-02-03 03:54:41

African Economic Development Initiative

Created on 2018-02-03 03:47:47

CFA

Created on 2018-02-03 03:46:31

American States University

Created on 2018-02-03 03:46:13

CBIS Consortium

Created on 2018-02-03 03:39:12

Key Management

Created on 2018-02-03 01:40:51

  • Start
  • Prev
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • Next
  • End
REACH US.

2019 US Federal Contractor

DUNS number: 830406356
CAGE code: 5FZM9

NAICS Codes selected:

541711 - Research and Development in Biotechnology

621511 - Medical Laboratories

624230 - Emergency And Other Relief Services

Contact.

Cannabis Science Inc.

Mr. Raymond C. Dabney
President & CEO

raymond.dabney@cannabisscience.com



 
 
Copyright © 2019 Cannabis Science Inc. All Rights Reserved.